The International Myeloma Foundation recently sponsored a satellite symposium at the Oncology Nursing Society annual conference held in Las Vegas, Nevada in April. The program, Management of Novel Therapeutics' Side Effects: A Nurse Centric Model, was sponsored by educational grants from Celgene Corporation and Millennium Pharmaceuticals. Presenters included chair Patricia Mangan, MSN, CRNP from the University of Pennsylvania; along with faculty members, Teresa Miceli, RN, BSN, Mayor Medical Center; Sandra Rome, RN, MN, AOCN, Cedars-Sinai Center; and Joseph D. Tariman, RN, APN, MN, APRN-BC, OCN®, University of Washington. The panel are members of the IMF’s Nurse Leadership Board. | | | Patricia Mangan, Teresa Miceli, Joseph D. Tariman, and Sandra Rome | This year's program had a high volume of interest with the largest pre-registration to date. The program presented the nurse centric model of care and addressed nursing issues along the continuum of side effects management from prevention to palliation. Attendee's comments included: "Great information - Very applicable for nurses and my practice - Best one yet" and "Good incorporation of nurse roles and nurse centric model. Excellent reinforcement of multiple myeloma diagnosis process and side effect management and treatment." | | | | Sandra Rome chatting with attendees | The IMF's Diane Moran and Teresa Miceli | | | | | Patricia Mangan | Joseph D. Tariman | Click the PDF icon to see the slide set from the symposium.
|